First report of a mucosa-associated lymphoid tissue (MALT) lymphoma of the esophagus diagnosed by endoscopic ultrasound-guided fine-needle aspiration (EUS-FNA)
Mucosa-associated lymphoid tissue (MALT) lymphoma of the esophagus is a rare tumor [1 -3] with varying presentations [4] . Only a few reports have de-scribed MALT lymphoma of the esophagus spanning the entire circumference and length of the esophagus [3] . Many of these cases were diagnosed surgically. Endoscopic ultrasound-guided fine-needle aspiration (EUS-FNA) is an established method of obtaining submucosal tissue specimens [5] . We report here the first case of MALT lymphoma of the esophagus diagnosed by EUS-FNA. A 60-year-old woman attended our institution due to dysphagia. Upper gastrointestinal endoscopy revealed a smooth surface with visible capillaries over the entire circumference of the esophagus and a white, soft, elastic submucosal tumor covered by normal mucosa (• " Fig. 1 ). An esophagogram showed a slightly elevated submucosal tumor extending over the entire esophageal length (• " Fig. 2) , and enhanced computed tomography demonstrated thickening of the left bronchial and esophageal walls along with swelling of the pharyngeal lymph nodes. Endoscopic ultrasonography revealed a tumorous lesion presenting as a primarily hypoechoic mass arising in the third layer, with a hyperechoic region. Because a diagnosis was not reached using specimens obtained with biopsy forceps, EUS-FNA was performed (• " Fig. 3) . The presence of small-to medium-sized lymphocytic cells with mildly irregular nuclei, along with CD5(-), CD10(-), CD19(+), CD20(+), CD22 (+), and λ monoclonality on flow cytometry, led to a diagnosis of MALT lymphoma of the esophagus (• " Fig. 4) . We described the tumor as a Fig. 1 Endoscopic findings in a 60-year-old woman with dysphagia: a large, rounded mass with normal overlying mucosa is seen extending longitudinally along the entire esophagus. malignant, extramarginal zone B-cell lymphoma of the MALT type, clinical stage IV (Lugano International Conference classification). The patient was treated with a total of six courses of chemotherapy with rituximab, cyclophosphamide, vincristine, doxorubicin, and prednisolone (R-CHOP), and a complete response was achieved. To the best of our knowledge, this is the first report of EUS-FNA diagnosis of MALT lymphoma of the esophagus. Endoscopy_UCTN_Code_CCL_1AB_2AC_3AB 
